Industry: Medical Devices & Consumables
Published Date: 2024-02-05
Pages: 91 Pages
Report ld: 2417792
Request Sample
Customized Report
Organ Chips Market Size(US$)

CAGR 2024-2030
31.2%
Market Size,2030
USD 622.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Organ Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and Organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The global Organ Chips market was valued at US$ 88 million in 2023 and is anticipated to reach US$ 622.5 million by 2030, witnessing a CAGR of 31.2% during the forecast period 2024-2030.
Global organ on chip key players include Emulate, TissUse, Mimetas, CN Bio Innovations, Valo Health, etc. Global top 5 manufacturers hold a share about 58%.
North America is the largest market, with a share about 42%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Liver-on-a-chip is the largest segment, with a share about 26%. And in terms of application, the largest application is pharmaceutical & biotechnology companies, followed by academic & research institutes.
This report aims to provide a comprehensive presentation of the global market for Organ Chips, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Chips.
MARKET SEGMENTATION
REPORT SCOPE
The Organ Chips market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Chips market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Chips companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Chips companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Chips Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market by End User
1.3.1 Global Organ Chips Market Growth by End User: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ Chips Market Perspective (2019-2030)
2.2 Organ Chips Growth Trends by Region
2.2.1 Global Organ Chips Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Organ Chips Historic Market Size by Region (2019-2024)
2.2.3 Organ Chips Forecasted Market Size by Region (2025-2030)
2.3 Organ Chips Market Dynamics
2.3.1 Organ Chips Industry Trends
2.3.2 Organ Chips Market Drivers
2.3.3 Organ Chips Market Challenges
2.3.4 Organ Chips Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ Chips Players by Revenue
3.1.1 Global Top Organ Chips Players by Revenue (2019-2024)
3.1.2 Global Organ Chips Revenue Market Share by Players (2019-2024)
3.2 Global Organ Chips Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organ Chips Revenue
3.4 Global Organ Chips Market Concentration Ratio
3.4.1 Global Organ Chips Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Chips Revenue in 2023
3.5 Organ Chips Key Players Head office and Area Served
3.6 Key Players Organ Chips Product Solution and Service
3.7 Date of Enter into Organ Chips Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ Chips Breakdown Data by Type
4.1 Global Organ Chips Historic Market Size by Type (2019-2024)
4.2 Global Organ Chips Forecasted Market Size by Type (2025-2030)
5 Organ Chips Breakdown Data by End User
5.1 Global Organ Chips Historic Market Size by End User (2019-2024)
5.2 Global Organ Chips Forecasted Market Size by End User (2025-2030)
6 North America
6.1 North America Organ Chips Market Size (2019-2030)
6.2 North America Organ Chips Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Organ Chips Market Size by Country (2019-2024)
6.4 North America Organ Chips Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ Chips Market Size (2019-2030)
7.2 Europe Organ Chips Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Organ Chips Market Size by Country (2019-2024)
7.4 Europe Organ Chips Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organ Chips Market Size (2019-2030)
8.2 Asia-Pacific Organ Chips Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Organ Chips Market Size by Region (2019-2024)
8.4 Asia-Pacific Organ Chips Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organ Chips Market Size (2019-2030)
9.2 Latin America Organ Chips Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Organ Chips Market Size by Country (2019-2024)
9.4 Latin America Organ Chips Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ Chips Market Size (2019-2030)
10.2 Middle East & Africa Organ Chips Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Organ Chips Market Size by Country (2019-2024)
10.4 Middle East & Africa Organ Chips Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ Chips Introduction
11.1.4 Emulate Revenue in Organ Chips Business (2019-2024)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Detail
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Organ Chips Introduction
11.2.4 Mimetas Revenue in Organ Chips Business (2019-2024)
11.2.5 Mimetas Recent Development
11.3 TissUse
11.3.1 TissUse Company Detail
11.3.2 TissUse Business Overview
11.3.3 TissUse Organ Chips Introduction
11.3.4 TissUse Revenue in Organ Chips Business (2019-2024)
11.3.5 TissUse Recent Development
11.4 Valo Health
11.4.1 Valo Health Company Detail
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Organ Chips Introduction
11.4.4 Valo Health Revenue in Organ Chips Business (2019-2024)
11.4.5 Valo Health Recent Development
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Detail
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Organ Chips Introduction
11.5.4 CN Bio Innovations Revenue in Organ Chips Business (2019-2024)
11.5.5 CN Bio Innovations Recent Development
11.6 Hesperos
11.6.1 Hesperos Company Detail
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Organ Chips Introduction
11.6.4 Hesperos Revenue in Organ Chips Business (2019-2024)
11.6.5 Hesperos Recent Development
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Detail
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Organ Chips Introduction
11.7.4 Draper Laboratory Revenue in Organ Chips Business (2019-2024)
11.7.5 Draper Laboratory Recent Development
11.8 Nortis
11.8.1 Nortis Company Detail
11.8.2 Nortis Business Overview
11.8.3 Nortis Organ Chips Introduction
11.8.4 Nortis Revenue in Organ Chips Business (2019-2024)
11.8.5 Nortis Recent Development
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Detail
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Organ Chips Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Organ Chips Business (2019-2024)
11.9.5 Micronit Microtechnologies B.V. Recent Development
11.10 Kirkstall
11.10.1 Kirkstall Company Detail
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Organ Chips Introduction
11.10.4 Kirkstall Revenue in Organ Chips Business (2019-2024)
11.10.5 Kirkstall Recent Development
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Detail
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Organ Chips Introduction
11.11.4 Cherry Biotech SAS Revenue in Organ Chips Business (2019-2024)
11.11.5 Cherry Biotech SAS Recent Development
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Detail
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Organ Chips Introduction
11.12.4 Else Kooi Laboratory Revenue in Organ Chips Business (2019-2024)
11.12.5 Else Kooi Laboratory Recent Development
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Detail
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Organ Chips Introduction
11.13.4 Altis Biosystems Revenue in Organ Chips Business (2019-2024)
11.13.5 Altis Biosystems Recent Development
11.14 Bi/ond
11.14.1 Bi/ond Company Detail
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Organ Chips Introduction
11.14.4 Bi/ond Revenue in Organ Chips Business (2019-2024)
11.14.5 Bi/ond Recent Development
11.15 Netri
11.15.1 Netri Company Detail
11.15.2 Netri Business Overview
11.15.3 Netri Organ Chips Introduction
11.15.4 Netri Revenue in Organ Chips Business (2019-2024)
11.15.5 Netri Recent Development
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Detail
11.16.2 Xona Microfluidics Business Overview
11.16.3 Xona Microfluidics Organ Chips Introduction
11.16.4 Xona Microfluidics Revenue in Organ Chips Business (2019-2024)
11.16.5 Xona Microfluidics Recent Development
11.17 SynVivo, Inc.
11.17.1 SynVivo, Inc. Company Detail
11.17.2 SynVivo, Inc. Business Overview
11.17.3 SynVivo, Inc. Organ Chips Introduction
11.17.4 SynVivo, Inc. Revenue in Organ Chips Business (2019-2024)
11.17.5 SynVivo, Inc. Recent Development
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Detail
11.18.2 Beijing Daxiang Biotech Business Overview
11.18.3 Beijing Daxiang Biotech Organ Chips Introduction
11.18.4 Beijing Daxiang Biotech Revenue in Organ Chips Business (2019-2024)
11.18.5 Beijing Daxiang Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Organ Chips was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 1003 million, growing at a CAGR of 25.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
The global Organ Chips market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 1003 million by 2032, at a CAGR of 25.4% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 119
USD 2900.00
(Single User License)
The global Organ Chips market size was US$ 171 million in 2024 and is forecast to a readjusted size of US$ 816 million by 2031 with a CAGR of 25.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 100
USD 4250.00
(Single User License)
The global Organ Chips market is projected to grow from US$ 171 million in 2024 to US$ 816 million by 2031, at a CAGR of 25.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 163
USD 4900.00
(Single User License)
The global market for Organ Chips was estimated to be worth US$ 171 million in 2024 and is forecast to a readjusted size of US$ 816 million by 2031 with a CAGR of 25.4% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 118
USD 3950.00
(Single User License)
The global market for Organ Chips was valued at US$ 171 million in the year 2024 and is projected to reach a revised size of US$ 816 million by 2031, growing at a CAGR of 25.4% during the forecast period.
Published Date: 2025-01-13
Pages: 97
USD 2900.00
(Single User License)
Organ Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and Organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published Date: 2024-04-28
Pages: 115
USD 4900.00
(Single User License)
The global market for Organ Chips was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 1003 million, growing at a CAGR of 25.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
The global Organ Chips market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 1003 million by 2032, at a CAGR of 25.4% from 2026 to 2032.
Published: 2026-04-17
Pages: 119
The global Organ Chips market size was US$ 171 million in 2024 and is forecast to a readjusted size of US$ 816 million by 2031 with a CAGR of 25.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 100
The global Organ Chips market is projected to grow from US$ 171 million in 2024 to US$ 816 million by 2031, at a CAGR of 25.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 163
The global market for Organ Chips was estimated to be worth US$ 171 million in 2024 and is forecast to a readjusted size of US$ 816 million by 2031 with a CAGR of 25.4% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 118
The global market for Organ Chips was valued at US$ 171 million in the year 2024 and is projected to reach a revised size of US$ 816 million by 2031, growing at a CAGR of 25.4% during the forecast period.
Published: 2025-01-13
Pages: 97
Organ Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and Organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published: 2024-04-28
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now